Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Cash & Equivalents (2016 - 2026)

American Healthcare REIT filings provide 10 years of Cash & Equivalents readings, the most recent being $151.8 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 23.08% to $151.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $151.8 million, a 23.08% increase, with the full-year FY2025 number at $151.8 million, up 23.08% from a year prior.
  • Cash & Equivalents hit $151.8 million in Q4 2025 for American Healthcare REIT, up from $147.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $151.8 million in Q4 2025 to a low of $35.2 million in Q3 2023.
  • Median Cash & Equivalents over the past 5 years was $78.2 million (2022), compared with a mean of $84.5 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 383.25% in 2021 and later tumbled 61.18% in 2023.
  • American Healthcare REIT's Cash & Equivalents stood at $81.6 million in 2021, then soared by 37.14% to $111.9 million in 2022, then tumbled by 61.18% to $43.4 million in 2023, then skyrocketed by 183.81% to $123.3 million in 2024, then increased by 23.08% to $151.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $151.8 million (Q4 2025), $147.4 million (Q3 2025), and $133.5 million (Q2 2025) per Business Quant data.